Avidian Wealth Solutions, LLC Clovis Oncology, Inc. Transaction History

Avidian Wealth Solutions, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 05, 2021	SELL	$4.81 - $10.34 $360,749 - $775,500	-75,000 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$4.13 - $6.41 $37,170 - $57,690	9,000 Added 13.64%	75,000 $360,000
Q3 2020 Feb 03, 2021	BUY	$4.82 - $7.72 $318,120 - $509,520	66,000 New	66,000 $385,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Avidian Wealth Solutions, LLC, based on Form 13F filings with the SEC.

Stay updated on Avidian Wealth Solutions, LLC with notifications on news.